Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 49.14B 7.37B 6.59B 6.09B 5.52B 10.33B 701B 10.49B 73.32B 29B 367B 27.64B 27.05B 1,160B | P/E 2026 * |
37.2x | P/E 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 43.97B 6.59B 5.89B 5.45B 4.94B 9.24B 627B 9.39B 65.61B 25.95B 328B 24.74B 24.21B 1,038B | EV / Sales 2026 * |
5.45x | EV / Sales 2027 * | 4.52x |
| Free-Float |
62.13% | Yield 2026 * |
0.9% | Yield 2027 * | 1.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 1998-10-06 |
Rui Yang
CEO | Chief Executive Officer | 49 | 2022-01-18 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.7B | |
| +0.57% | +3.13% | +54.78% | +125.16% | 1,135B | |
| +0.52% | +4.53% | +39.41% | +78.05% | 635B | |
| +0.16% | +1.16% | +25.40% | +96.94% | 505B | |
| +1.43% | +4.31% | +48.28% | +67.12% | 378B | |
| -3.02% | -1.90% | +60.11% | +33.49% | 358B | |
| -0.41% | +2.64% | +23.58% | +49.82% | 295B | |
| +0.23% | +3.66% | +2.45% | +23.69% | 266B | |
| +0.32% | +3.71% | +51.37% | +63.40% | 237B | |
| +1.37% | +3.31% | +31.27% | +101.45% | 193B | |
| Average | +0.14% | +1.60% | +37.41% | +71.01% | 444.85B | |
| Weighted average by Cap. | +0.22% | +1.63% | +41.39% | +83.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.06B 1.21B 1.08B 1B 905M 1.69B 115B 1.72B 12.03B 4.76B 60.14B 4.54B 4.44B 190B | 9.89B 1.48B 1.33B 1.23B 1.11B 2.08B 141B 2.11B 14.75B 5.84B 73.74B 5.56B 5.44B 233B |
| Net income | 1.35B 202M 180M 167M 151M 283M 19.2B 288M 2.01B 795M 10.04B 757M 741M 31.8B | 1.78B 267M 239M 221M 200M 374M 25.39B 380M 2.66B 1.05B 13.28B 1B 980M 42.05B |
| Net Debt | -5.17B -775M -693M -641M -580M -1.09B -73.72B -1.1B -7.71B -3.05B -38.56B -2.91B -2.85B -122B | -4.41B -661M -591M -547M -495M -927M -62.89B -942M -6.58B -2.6B -32.89B -2.48B -2.43B -104B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
